On this page
Evidence dossier
The report behind the claim
The authors reported improved healing-related findings in the experimental surgical model. The paper does not establish improved outcomes after human esophageal surgery.
Esophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAME.
- Design
- Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
- Participants or model
- Rats after esophagogastric anastomosis
- Endpoint
- Anastomotic strength, lesions and sphincter-related function
- Finding on record
- The authors reported improved healing-related findings in the experimental surgical model.
- Limits of inference
- The paper does not establish improved outcomes after human esophageal surgery.
The experiment in view
The study used rats after esophagogastric anastomosis. Its principal measures were anastomotic strength, lesions and sphincter-related function. The authors reported improved healing-related findings in the experimental surgical model.
Reading the result closely
A joined segment has mechanical and functional demands that a superficial wound does not share. Anastomotic strength matters because a neat-looking surface may still leak or fail under pressure. The surgical setting should stay in the headline rather than disappearing behind a general healing claim.
The boundary of the finding
The paper does not establish improved outcomes after human esophageal surgery.
Related evidence, kept separate
BPC-157 in a perforated-cecum experiment examines vessel appearance, bleeding, defect contraction, later lesions and adhesions. Here, the measured endpoint was anastomotic strength, lesions and sphincter-related function. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with the What changes when a BPC-157 paper becomes a sales claim? appraisal.
On the record
The documents supporting this report.